In particular, a recent study showed that the reduction of phosphorylated PKB/Akt levels correlated with the enhancement of gemcitabine-induced apoptosis and antitumour activity, suggesting that the PI3K-Akt pathway plays a significant role in mediating drug sensitivity in human cancer cells (Ng et al, 2000). This evidence concerns the gene AKT1 and cancer.